公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | Birth order and risk of nasopharyngeal carcinoma in multiplex families from Taiwan | Liu Z; Coghill A.E; Pfeiffer R.M; Hsu W.-L; PEI-JEN LOU ; CHENG-PING WANG ; Yu K.J; Niwa S; Brotzman M; Ye W; Chen C.-J; Hildesheim A. | International Journal of Cancer | 0 | 0 | |
2018 | Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants | Coghill A.E; Hsu W.-L; Yang Q; CHENG-PING WANG ; PEI-JEN LOU ; Yu K.J; Yu G; Diehl S.R; Chen C.-J; Goldstein A.M; Hildesheim A. | Journal of General Virology | 3 | 3 | |
2014 | Epstein-barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan | Coghill A.E; Hsu W.-L; Pfeiffer R.M; Juwana H; Yu K.J; PEI-JEN LOU ; CHENG-PING WANG ; Chen J.-Y; Chen C.-J; Middeldorp J.M; Hildesheim A. | Cancer Epidemiology Biomarkers and Prevention | 56 | 45 | |
2020 | Erratum: Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929) | Coghill A.E; Pfeiffer R.M; Proietti C; Hsu W.-L; Chien Y.-C; Lekieffre L; Krause L; Teng A; Pablo J; Yu K.J; PEI-JEN LOU ; CHENG-PING WANG ; Liu Z; Chen C.-J; Middeldorp J; Mulvenna J; Bethony J; Hildesheim A; Doolan D.L. | Clinical cancer research : an official journal of the American Association for Cancer Research | 0 | 0 | |
2018 | Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma | Coghill A.E; CHENG-PING WANG ; Verkuijilen S.A.W.M; Yu K.J; Hsu W.-L; Middeldorp J.M; Hildesheim A. | Journal of Medical Virology | 14 | 13 | |
2016 | High levels of antibody that neutralize b-cell infection of Epstein-barr virus and that bind ebv gp350 are associated with a lower risk of nasopharyngeal carcinoma | Coghill A.E; Bu W; Nguyen H; Hsu W.-L; Yu K.J; PEI-JEN LOU ; CHENG-PING WANG ; Chen C.-J; Hildesheim A; Cohen J.I. | Clinical Cancer Research | 31 | 27 | |
2018 | Identification of a Novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan | Coghill A.E; Pfeiffer R.M; Proietti C; Hsu W.-L; Chien Y.-C; Lekieffre L; Krause L; Teng A; Pablo J; Yu K.J; PEI-JEN LOU ; CHENG-PING WANG ; Liu Z; Chen C.-J; Middeldorp J; Mulvenna J; Bethony J; Hildesheim A; Doolan D.L. | Clinical Cancer Research | 44 | 37 | |
2019 | Multilaboratory assessment of Epstein-Barr virus serologic assays: The case for standardization | Liu Z; Yu K.J; Coghill A.E; Brenner N; Cao S.-M; Chen C.-J; Chen Y; Doolan D.L; Hsu W.-L; Labo N; Middeldorp J.M; Miley W; Simon J; CHENG-PING WANG ; Waterboer T; Whitby D; Xie S.-H; Ye W; Hildesheim A. | Journal of Clinical Microbiology | 6 | 7 | |
2018 | Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome | Liu Z; Coghill A.E; Pfeiffer R.M; Proietti C; Hsu W.-L; Chien Y.-C; Lekieffre L; Krause L; Yu K.J; PEI-JEN LOU ; CHENG-PING WANG ; Mulvenna J; Middeldorp J.M; Bethony J; Chen C.-J; Doolan D.L; Hildesheim A. | Journal of Infectious Diseases | 13 | 12 | |
2020 | Validation of an Epstein-Barr virus antibody risk stratification signature for nasopharyngeal carcinoma by use of multiplex serology | Simon J; Liu Z; Brenner N; Yu K.J; Hsu W.-L; CHENG-PING WANG ; Chien Y.-C; Coghill A.E; Chen C.-J; Butt J; Proietti C; Doolan D.L; Hildesheim A; Waterboer T. | Journal of Clinical Microbiology | 11 | 10 | |
2019 | Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma | Yu G; Hsu W.-L; Coghill A.E; Yu K.J; CHENG-PING WANG ; PEI-JEN LOU ; Liu Z; Jones K; Vogt A; Wang M; Mbulaiteye S.M; Chen H.-H; Boland J; Yeager M; Diehl S.R; Chen C.-J; Hildesheim A; Goldstein A.M. | Scientific Reports | 30 | 26 |